Perrigo Company plc Stock News

The FDA just approved the first over-the-counter birth control pill -- Perrigo's Opill. There could be a significant demand for the OTC oral contraceptive.

Ibis Reproductive Health President Kelly Blanchard spoke with Yahoo Finance Live anchor Rachelle Akuffo about the FDA approval of Perrigo's Opill to be sold over the counter in the United States.

Yahoo Finance Live anchors Julie Hyman and Brad Smith break down the U.S. Food and Drug Administration approving Perrigo over-the-counter birth control pill named OPill. It is the first approval of an

Perrigo's Opill could significantly expand access to contraception, especially for younger women who often face logistical barriers to get birth control.

The drug will be available in store and online at retailers across the country 'early in the first quarter of 2024,' the company says.

Patterson (PDCO), Perrigo (PRGO) and GSK are three healthcare stocks that can lend solidity to one's portfolio today and provide big returns in the foreseeable future.

Perrigo Co. PLC's stock PRGO, -0.78% soared 6% in premarket trade Thursday, after the company said the U.S. Food and Drug Administration has approved its over-the-counter daily oral contraceptive. The

The U.S. Food and Drug Administration on Thursday approved the over-the-counter use of Perrigo's contraceptive drug, making it the first non-prescription birth control pill in the United States.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

The mean of analysts' price targets for Perrigo (PRGO) points to a 49.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts

Perrigo is repositioning itself as an exclusively consumer-facing over-the-counter brand, streamlining its sales process, and expanding its market through acquisitions. PRGO's Opill contraceptive is e

Perrigo Co. Plc PRGO, +0.51% on Thursday named Patrick Lockwood-Taylor as its new president and chief executive officer as of June 30. Lockwood-Taylor previously worked in dual roles at Bayer AG as pr

The heavy selling pressure might have exhausted for Perrigo (PRGO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest